Kransdorf M J, Sweet D E
Department of Radiology, Saint Mary's Hospital, Richmond, VA 23226.
AJR Am J Roentgenol. 1995 Mar;164(3):573-80. doi: 10.2214/ajr.164.3.7863874.
The aneurysmal bone cyst is the result of a specific pathophysiologic change, which is probably the result of trauma or a tumor-induced anomalous vascular process. In approximately one third of cases, the preexisting lesion can be clearly identified. The most common of these is the giant cell tumor, which accounts for 19-39% of cases in which the preceding lesion is found. Other common precursor lesions include osteoblastoma, angioma, and chondroblastoma. Less common lesions include fibrous dysplasia, fibroxanthoma (nonossifying fibroma), chondromyxoid fibroma, solitary bone cyst, fibrous histiocytoma, eosinophilic granuloma, and even osteosarcoma. Interestingly, some of the controversy surrounding this lesion may be the result of a change in how the lesion was defined by Lichtenstein in 1953, when intramedullary lesions were added to the previously described juxtacortical (superficial) lesions. Members of the AFIP have suggested that many of the intramedullary lesions in which no previous lesion can be identified may represent giant cell tumors of bone. Their similarity to proved giant cell tumors in skeletally immature patients can be striking and seems more than coincidental. Appropriate treatment of an aneurysmal bone cyst requires the realization that it results from a specific pathophysiologic process, and identification of the preexisting lesion, if possible, is essential. Clearly an osteosarcoma with superimposed secondary aneurysmal bone cyst change must be treated as an osteosarcoma, and giant cell tumor with secondary features of aneurysmal bone cyst would be expected to be more likely to recur locally. The vast majority (approximately 80%) of patients presenting with aneurysmal bone cystlike findings are less than 20 years old. More than half of all such lesions occur in long bones, with approximately 12-30% of cases occurring in the spine. The pelvis accounts for about half of all flat bone lesions. Most patients present with pain and/or swelling, with symptoms usually present for less than 6 months. The imaging appearance of aneurysmal bone cyst reflects the underlying pathophysiologic change. Radiographs show an eccentric, lytic lesion with an expanded, remodeled "blown-out" or "ballooned" bony contour of the host bone, frequently with a delicate trabeculated appearance. Radiographs may rarely show flocculent densities within the lesion, which may mimic chondroid matrix. CT scanning will define the lesion and is especially valuable for those lesions located in areas in which the bony anatomy is complex, and which are not adequately evaluated by plain films. Fluid-fluid levels are common and may be seen on CT scans and MR images.(ABSTRACT TRUNCATED AT 250 WORDS)
动脉瘤样骨囊肿是特定病理生理变化的结果,这可能是创伤或肿瘤诱导的异常血管过程所致。在大约三分之一的病例中,可以明确识别先前存在的病变。其中最常见的是骨巨细胞瘤,在发现先前病变的病例中占19% - 39%。其他常见的前驱病变包括骨母细胞瘤、血管瘤和成软骨细胞瘤。较少见的病变包括骨纤维异常增殖症、纤维黄色瘤(非骨化性纤维瘤)、软骨黏液样纤维瘤、孤立性骨囊肿、纤维组织细胞瘤、嗜酸性肉芽肿,甚至骨肉瘤。有趣的是,围绕该病变的一些争议可能是由于1953年利希滕斯坦对病变定义的改变,当时将髓内病变添加到先前描述的皮质旁(浅表)病变中。武装部队病理研究所的成员认为,许多无法识别先前病变的髓内病变可能代表骨巨细胞瘤。它们与骨骼未成熟患者中已证实的骨巨细胞瘤的相似性可能非常显著,而且似乎并非巧合。对动脉瘤样骨囊肿进行适当治疗需要认识到它是由特定病理生理过程引起的,并且如果可能的话,识别先前存在的病变至关重要。显然,伴有继发性动脉瘤样骨囊肿改变的骨肉瘤必须按骨肉瘤治疗,而具有动脉瘤样骨囊肿继发性特征的骨巨细胞瘤预计更可能局部复发。绝大多数(约80%)表现出动脉瘤样骨囊肿样表现的患者年龄小于20岁。所有此类病变中超过一半发生在长骨,约12% - 30%的病例发生在脊柱。骨盆占所有扁平骨病变的约一半。大多数患者表现为疼痛和/或肿胀,症状通常出现不到6个月。动脉瘤样骨囊肿的影像学表现反映了潜在的病理生理变化。X线片显示偏心性溶骨性病变,宿主骨的骨轮廓呈膨胀、重塑的“吹胀”或“气球样”,通常具有精细的小梁外观。X线片很少能显示病变内的絮状密度,这可能类似于软骨样基质。CT扫描将明确病变,对于位于骨解剖结构复杂且平片评估不充分区域的病变尤其有价值。液 - 液平面很常见,在CT扫描和磁共振成像上都可能看到。(摘要截断于250字)